Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to give your agreement (consent) to take part in the study.
- You have been diagnosed with ALS (also known as Lou Gehrig's disease) and have weakness in both arms.
- Your ALS has not responded to treatment and you have had it for at least six months.
- You are 22 years old or older.
- Your doctors expect you to live for more than 12 months after the device is implanted.
- A CT scan shows that a specific area of your brain (involved in movement) is in good enough condition for the study (confirm with trial site).
- A CT scan of your blood vessels shows that your anatomy is suitable for the procedure (confirm with trial site).
- Your body has a suitable area under the skin where a small device pouch can be created (confirm with trial site).
- You are able to safely receive general anesthesia (be put to sleep for a procedure).
- You are willing and able to attend all required clinic visits and training sessions, including some at home.
- You have a caregiver who is willing and able to help with study visits — both at the clinic and at home — and assist with the device outside of visits (such as charging it).
- Both you and your caregiver speak and understand English fluently.
- Your home environment is suitable for brain-computer interface (BCI) training sessions.
Who may not be able to join:
- You have an active infection or an unexplained fever in the 48 hours before signing up for the study.
- You have a significant mental health condition that could affect your safety or ability to follow the study requirements, such as severe depression, psychosis, personality disorder, severe mood instability, or substance misuse.
- You have been diagnosed with ALS combined with dementia (ALS-FTD) or any other form of dementia.
- You already have an active implanted medical device, such as a pacemaker, deep brain stimulator, or similar device.
- You have a known allergy to any of the materials used in the implanted device.
- You cannot have certain types of imaging scans or a specific dye (contrast) used during those scans.
- You have a history of blood clots in the large veins of the brain (central venous sinus thrombosis).
- You have had a blood clot (such as a deep vein thrombosis or pulmonary embolism) in the past six months, have a history of repeated blood clots, or have a condition that makes your blood clot more easily than normal.
- You cannot take blood-thinning medications for any reason.
- You have a significantly increased risk of infection — for example, due to a weakened immune system, frequent or ongoing infections, or poorly controlled diabetes.
- There is a significant risk that a surgical wound on your skin would not heal properly, such as a history of wounds that did not heal or poorly controlled diabetes.
- You are currently pregnant or breastfeeding.
- You are currently enrolled in another clinical trial that could affect the results or requirements of this study.
- You have any other condition that could significantly affect your ability to participate — for example, vision or hearing problems that would make it difficult to use a computer screen or follow spoken instructions during training (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Device-related serious adverse events up to 180 days after implant
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.